Literature DB >> 22609092

Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4α).

E Scharmach1, T Buhrke, D Lichtenstein, A Lampen.   

Abstract

Perfluorooctanoic acid (PFOA) is an industrial chemical that is a global contaminant of water, soil and foodstuff. Numerous animal studies have revealed that PFOA has embryotoxic and hepatotoxic effects in rodents. On the molecular level, the adverse effects of PFOA have been correlated with the PFOA-mediated activation of peroxisome proliferator-activated receptor alpha (PPARα), however, the toxicological relevance of this mode of action for humans is under debate. In this study, a proteomic approach was chosen to screen for molecular targets affected by PFOA in human liver cells. Treatment of the human liver cell line HepG2 with 25 μM PFOA resulted in 51 deregulated proteins in a two-dimensional gel experiment, and 36 of these proteins were identified by mass spectrometry. Network analysis revealed that these proteins are primarily involved in lipid metabolism and cancer. The hepatocyte nuclear factor 4α (HNF4α), but not PPARα, was the key regulator of the network. Indeed, subsequent western blot analysis revealed that the amount of HNF4α as well as of its target HNF1α was downregulated in PFOA-treated HepG2 cells. Moreover, PFOA was shown to inhibit HNF4α-dependent gene transcription. Thus, this study provides first experimental evidence that HNF4α is negatively affected by PFOA.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609092     DOI: 10.1016/j.toxlet.2012.05.007

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  11 in total

1.  Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009-2014.

Authors:  Franco Scinicariello; Melanie C Buser; Lina Balluz; Kimberly Gehle; H Edward Murray; Henry G Abadin; Roberta Attanasio
Journal:  Chemosphere       Date:  2020-06-20       Impact factor: 7.086

2.  Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2019-05-28       Impact factor: 9.621

3.  Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-19       Impact factor: 4.219

4.  The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.

Authors:  Kevin M Beggs; Steven R McGreal; Alex McCarthy; Sumedha Gunewardena; Jed N Lampe; Christoper Lau; Udayan Apte
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-03       Impact factor: 4.219

5.  PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.

Authors:  Mitchell B Rosen; Kaberi P Das; John Rooney; Barbara Abbott; Christopher Lau; J Christopher Corton
Journal:  Toxicology       Date:  2017-05-27       Impact factor: 4.221

6.  Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study.

Authors:  Gang Liu; Klodian Dhana; Jeremy D Furtado; Jennifer Rood; Geng Zong; Liming Liang; Lu Qi; George A Bray; Lilian DeJonge; Brent Coull; Philippe Grandjean; Qi Sun
Journal:  PLoS Med       Date:  2018-02-13       Impact factor: 11.069

7.  Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women.

Authors:  Qi Sun; Geng Zong; Damaskini Valvi; Flemming Nielsen; Brent Coull; Philippe Grandjean
Journal:  Environ Health Perspect       Date:  2018-03-01       Impact factor: 9.031

8.  Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.

Authors:  Gang Liu; Bo Zhang; Yang Hu; Jennifer Rood; Liming Liang; Lu Qi; George A Bray; Lilian DeJonge; Brent Coull; Philippe Grandjean; Jeremy D Furtado; Qi Sun
Journal:  Environ Health       Date:  2020-01-13       Impact factor: 5.984

9.  Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells.

Authors:  Anne-Cathrin Behr; Anna Kwiatkowski; Marcus Ståhlman; Felix Florian Schmidt; Claudia Luckert; Albert Braeuning; Thorsten Buhrke
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

Review 10.  PFAS Environmental Pollution and Antioxidant Responses: An Overview of the Impact on Human Field.

Authors:  Marco Bonato; Francesca Corrà; Marta Bellio; Laura Guidolin; Laura Tallandini; Paola Irato; Gianfranco Santovito
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.